Leaderboard

En | De
Sie sind hier: Onkologie 17. Juli 2026
Suchen
medline.ch
Onkologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 97792  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 1955835  
   
BRK/PTK6 in breast cancer: prognostic and therapeutic significance.
Cancer Treat Res Commun
Dokunmu TM, Nnaji FC, Amuji DN, Wakai TN, Amadi EC.
PMID: 42462367 [PubMed - as supplied by publisher]


Short-Term Effects of Comprehensive Periodontal Initial Therapy on Subgingival Microbiota in Nasopharyngeal Carcinoma Patients Undergoing Radiotherapy: A Pilot Randomised Controlled Trial.
Int Dent J
Lv S, Xu Z, He Q, Wu Y, Chen L.
PMID: 42462348 [PubMed - as supplied by publisher]


Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 Patients.
Clin Lung Cancer
Dimitriou K, Shi S, Marginenau A, Blasi M, Bozorgmehr F, Klotz LV, Eichhorn F, Schneider MA, Allgäuer M, Shah R, Bischoff H, Weykamp F, Stenzinger A, Thomas M, Christopoulos P.
PMID: 42462290 [PubMed - as supplied by publisher]


Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF.
ESMO Open
Bartolini M, Algaze S, Lenz HJ.
PMID: 42462280 [PubMed - as supplied by publisher]


Impact of prior conventional irinotecan use on nanoliposomal irinotecan efficacy in advanced pancreatic cancer: a meta-analysis.
ESMO Open
Lee S, Correa TL, Birda V, Roshan K, Peters ML, Modest AM, Keko M, Bockorny B.
PMID: 42462278 [PubMed - as supplied by publisher]


Quality of Life, Symptom Burden, and Associated Factors Among Patients With Lung Cancer in Sub-Saharan Africa: Cross-Sectional Study.
JMIR Cancer
Ratshikana M, Malale K, Sayed AR, Ayeni O, Mathobela P, Mathiba R, Blanchard C, Tsitsi M, Osei-Fofie D, Graham A, Dhudha HO, Masalu N.
PMID: 42462209 [PubMed - as supplied by publisher]


Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.
J Clin Oncol
Nahleh Z, Alfano CM, Somerfield MR, Lee JM, Hieken TJ, Magnuson A, Rao RD, Chew HK, Chia SKL, Harvey BE, Landsberger E, Lim B, Mwanzi SA, Parsons HA, Patt D, Sukumar JS, Sung H, Werutsky G, Lustberg M.
PMID: 42462191 [PubMed - as supplied by publisher]


Advances in Systemic Therapies for Rare Head and Neck Malignancies: Spotlight on Adenoid Cystic Carcinoma, Differentiated Thyroid Cancer, and Sinonasal/Paranasal Tumors.
Am Soc Clin Oncol Educ Book
Roberts TJ, Keam B, London NR Jr, Lechner M, Agosto Salgado S.
PMID: 42462190 [PubMed - as supplied by publisher]


Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study.
JCO Clin Cancer Inform
La J, Wang L, Corrigan JK, Lang D, Do NV, Brophy MT, Fillmore NR, Paller CJ.
PMID: 42462188 [PubMed - as supplied by publisher]


Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026). Part II: Evaluation and Management of Metastatic Castration-Resistant Prostate Cancer.
J Urol
Scarpato KR, Cookson MS, Dreicer R, Sayan M, Yu A, D'Anci KE, Pak LJ, Kirkby E.
PMID: 42462145 [PubMed - as supplied by publisher]


Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer.
J Urol
Scarpato KR, Cookson MS, Dreicer R, Sayan M, Yu A, D'Anci KE, Pak LJ, Kirkby E.
PMID: 42462144 [PubMed - as supplied by publisher]


Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome.
Clin J Oncol Nurs
Miller DM.
PMID: 42462106 [PubMed - indexed for MEDLINE]


Navigating Acute and Late-Onset Toxicities After Chimeric Antigen Receptor T-Cell Therapy: A Patient-Centered Nursing Approach.
Clin J Oncol Nurs
Ow KV.
PMID: 42462102 [PubMed - indexed for MEDLINE]


The Effect of Teriparatide in a Brown Tumor Patient With Pathological Hip Fracture: A Case Report and Literature Review.
JBJS Case Connect
Abdel-Hadi D, Al Lawati A, Al Farkani A, Al Badaai Y, Al Farii H.
PMID: 42462050 [PubMed - indexed for MEDLINE]


AI-Enhanced Predictive Analytics to Optimize Tele-Oncology Implementation in Rural Settings: Scoping Review.
JMIR Cancer
Husain L, Mullins M, Etingen B, Zafar RM, Siddiqui M, Jackson GL.
PMID: 42461982 [PubMed - indexed for MEDLINE]


Evaluating Large Reasoning Models Versus Human Multidisciplinary Teams in Lung Cancer Decision-Making: Real-World Study.
J Med Internet Res
Viculin I, Vrdoljak J, Tomi, Canjko I, , , Bo, Dru, Vukovi, Dunkic N, Popovi, Mladinov S, Bo, Vrdoljak E.
PMID: 42461960 [PubMed - indexed for MEDLINE]


Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.
PLoS One
Mäenpää N, Tiainen L, Martikainen J, Tanner M, Jukkola A, Bärlund M.
PMID: 42461910 [PubMed - indexed for MEDLINE]


Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards.
Oncol Res Treat
Vorwerk J, Leypoldt L, Schwandt J, Kohler J, Nimmagadda SC, Ahmed H, Patnana PK, Hönemann H, Helbing T, Feierabend S, Dazert E, Oelschläger L, Beder T, Bastian L, Sommer F, Zech H, Kriegs M, Dauth A, Ailani D, Albers-Leischner C, Christopeit M, Heckl S, Busch H, Habig S, Ückert F, Fliedner SMJ, Gebauer N, von Bubnoff N, Khandanpour C, Huber K.
PMID: 42461906 [PubMed - as supplied by publisher]


Retraction: Automated brain tumor diagnostics: Empowering neuro-oncology with deep learning-based MRI image analysis.
PLoS One
PLOS One Editors.
PMID: 42461855 [PubMed - in process]


Impact of Hypertrophy-Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial.
Curr Protoc
Braceras Arias P, Burgos Postigo S, B Alejo L.
PMID: 42461827 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 1955835    Seite 1 von 97792  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1